Investing in cannabis stocks is back in focus as regulatory progress and expanding medical use steadily lift demand. The ...

In December, President Donald Trump in an executive order told his attorney general to expediate a rulemaking process related to rescheduling marijuana as a less-dangerous drug.

Recent regulatory developments have improved the landscape of the cannabis industry in the U.S. Canopy Growth and Aurora ...

A group of American public legal officials expressed concern about current federal law covering hemp. They feel that although it was legalized in 2018, it's only poorly defined in federal law. The ...

Multiple news reports this week said that President Trump is expected to reclassify marijuana’s drug scheduling, which would lessen restrictions on its use and potentially allow companies that operate ...

Many cannabis stocks have experienced significant growth over the past six months. For instance, shares of Tilray Brands ( ...

Trump is reportedly mulling an executive order to downgrade marijuana to a Schedule III drug, which could open the door to banking services Tilray's stock, and shares of other cannabis companies, ...

Cannabis stocks surged Friday in the wake of reports that President Trump is preparing to reclassify marijuana under federal law — a long-awaited shift that investors say could loosen restrictions and ...

Major cannabis ETFs recorded their best-ever weekly gains on Friday after media reports indicated that President Donald Trump will soon issue an executive order to reclassify marijuana as a less ...